CORDIS · 322953 · FP7
NIPD A Novel Non-Invasive Prenatal Diagnosis for Genetic Disorders
Coordinator: NIPD GENETICS PUBLIC COMPANY LIMITED (CY)
Non-Invasive Prenatal Diagnosis (NIPD) has been one of the most fascinating research fields during the last decade. The identification of small amounts of fetal DNA in maternal circulation has opened new possibilities for NIPD. Up until today, two methods have achieved accurate and validated NIPD methods for trisomy 21. The first NIPD for trisomy 21 was based on next generation sequencing and the second was developed by our group and is based on a MeDIP real time qPCR. However, nothing has been achieved for the NIPD of other genomic disorders caused by pathogenic copy number changes or mutati…
About Seventh Framework Programme (2007–2013)
The Seventh Framework Programme (FP7) ran from 2007 to 2013 and was the EU's main research-funding instrument of that period. It mobilised roughly €50 billion across cooperation projects, ERC frontier grants, Marie Curie fellowships, capacity-building actions and Euratom research. FP7 closed to new calls in 2013 but its projects continued for years after under their original grant agreements.
EU contribution: €2.5M awarded to the consortium. The project runs over approximately 6 years from 2013-05-01 to 2019-04-30.
Full record on CORDIS — partners, deliverables, publications, news.
Open on cordis.europa.eu →More from CY
see all →- PHAETHON — PHAETHON Research and Innovation Centre of Excellence for Intelligent, Efficient and Sustainable Energy Solutions101059898 · HORIZON · €15.0M
- EXCELSIOR — ERATOSTHENES: Excellence Research Centre for Earth Surveillance and Space-Based Monitoring of the Environment857510 · H2020 · €15.0M
- KIOS CoE — KIOS Research and Innovation Centre of Excellence739551 · H2020 · €15.0M
- CY-BIOBANK — Biobanking and the Cyprus Human Genome Project857122 · H2020 · €15.0M
- CMMI – MaRITeC-X — Marine and Maritime Research, Innovation, Technology Centre of Excellence857586 · H2020 · €15.0M
- Water-Futures — Smart Water Futures: designing the next generation of urban drinking water systems951424 · H2020 · €10.0M
Other FP7 projects
see all →- COST II — Provision of Scientific, Technical and Administrative Management of COST200443 · FR · €250.0M
- COMBACTE-NET — Combatting Bacterial Resistance in Europe115523 · SE · €109.4M
- EUC²LID — European Lead Factory115489 · DE · €80.0M
- COMBACTE-MAGNET — Combatting Bacterial Resistance in Europe - Molecules against Gram Negative Infections115737 · SE · €75.3M
- ENABLE — European Gram Negative Antibacterial Engine115583 · UK · €58.9M
- PLACES2BE — Pilot Lines for Advanced CMOS EmbodimentS in 2x nodes, Built in Europe325633 · FR · €52.6M
Frequently asked questions
- Who funds this research project?
- This project is funded by the European Union through the Seventh Framework Programme (2007–2013) programme, under the ERC-AG funding scheme.
- What is the EU contribution?
- The European Commission contributes €2.5M toward a total project budget of €2.5M.
- Which EU programme funds it?
- The project is funded under Seventh Framework Programme (2007–2013).
- Who coordinates the project?
- The project is coordinated by NIPD GENETICS PUBLIC COMPANY LIMITED (CY).
- What is the project timeline?
- The project runs from 2013-05-01 to 2019-04-30 — approximately 6 years.
- Where can I find the full project record?
- The complete record — partners, deliverables, publications and news — is published on CORDIS under project ID 322953.